Ohlbe
★★★

France,
2020-04-28 23:01

Posting: # 21358
Views: 2,126
 

 FDA recommendations on BE trials during the pandemic [Regulatives / Guidelines]

Dear all,

The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence.

Regards
Ohlbe
Activity
 Admin contact
20,648 posts in 4,328 threads, 1,436 registered users;
online 26 (1 registered, 25 guests [including 11 identified bots]).
Forum time: 12:23 CEST (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5